Big Pharma Set to Let Biotech Bleed Continue Before Deploying Massive Cash Balances
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2022/06/wengang-zhai-BFB7ydn1-DI-unsplash-1024x683.jpg)
Throughout the past few months, MRP has highlighted significant cash balances among many biopharmaceutical giants. Though hundreds of billions of dollars…
McAlinden Research PartnersJune 14, 2022